Blood-Based Marker Plus PLCO Risk Model Can ID Lethal Lung Cancer
THURSDAY, July 13, 2023 (HealthDay News) — A blood-based biomarker panel combined with the Prostate, Lung, Colorectal, and Ovarian (PLCO) risk model (PLCOm2012) can identify individuals at high risk of lethal lung cancer, according to a study publish…
Learn MoreAumentan ciertos tipos de cáncer entre los hispanos de EE. UU.
LUNES, 3 de julio de 2023 (HealthDay News) — Las tasas de mortalidad por cáncer entre los estadounidenses de origen hispano se han reducido en general en las dos últimas décadas, pero las perspectivas han empeorado en ciertos tipos de cáncer, encuent…
Learn MoreStaying Fit Lowers a Man’s Cancer Risk, Study Confirms
MONDAY, July 3, 2023 (HealthDay News) — A man’s cardio fitness might influence whether he’ll develop — or survive — three of the most common cancers in males, a new Swedish study reports.Higher levels of cardio fitness are associated with a signifi…
Learn MoreCertain Cancers Are on the Rise Among Hispanic Americans
MONDAY, July 3, 2023 (HealthDay News) — Cancer death rates among Hispanic Americans have declined in general over the past two decades, but for certain cancers the outlook has only gotten worse, a new study finds.First, the good news: Thanks to impro…
Learn More2019 to 2021 Saw Rise in Lung Cancer Screenings
THURSDAY, June 22, 2023 (HealthDay News) — The prevalence of lung cancer screening (LCS) increased in 2021 versus 2019, according to a research letter published online June 21 in JAMA Network Open.Kristin G. Maki, Ph.D., from Wayne State University S…
Learn MoreFewer Black Veterans Complete Referrals for Lung Cancer Screening
FRIDAY, June 16, 2023 (HealthDay News) — Black veterans have significantly lower odds of completing lung cancer screening (LCS) than White veterans even after adjusting for demographic and socioeconomic risk factors, according to a study published on…
Learn MoreAlectinib Exposure Lower With Low-Fat Yogurt Intake
WEDNESDAY, June 14, 2023 (HealthDay News) — For patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer, alectinib exposure is lower when taken with low-fat yogurt, according to a study published in the June issue of the…
Learn MoreLow-Fat Breakfasts Could Weaken Effect of a Key Lung Cancer Drug
WEDNESDAY, June 14, 2023 (HealthDay News) — The lung cancer drug alectinib (Alecensa) is more potent when taken with a fuller breakfast, or lunch, than when taken with a low-fat breakfast, researchers report. The Dutch team evaluated 20 patients who …
Learn MoreDos años de inmunoterapia para un cáncer de pulmón avanzado podrían ser suficientes, según un estudio
VIERNES, 9 de junio de 2023 (HealthDay News) — Las perspectivas de supervivencia han aumentado de forma significativa para los pacientes con un cáncer de pulmón en etapa tardía, desde la llegada de medicamentos conocidos como inhibidores de puntos de…
Learn More2 Years of Immunotherapy for Advanced Lung Cancer Might Be Enough: Study
FRIDAY, June 9, 2023 (HealthDay News) — For patients battling late-stage lung cancer, prospects for survival have improved significantly since the advent of medications known as immune checkpoint inhibitors.But exactly how long patients with advanced…
Learn More